Compare companies
Sector
Report publication year
This is a small selection of the indicators assessed within the Framework. Use the drop-down options above to focus on a particular sector or publication year. Click on the company name to view the individual dashboard, or for a comprehensive insight download the latest full dataset. Presence of a dash (–) indicates there is no data related to this metric. Additional companies and financial years will be added as assessments become available.
| Name | Living wage accredited | Tax reporting (GRI 207) | Remuneration committee discretion (direction) | Director from workforce | Trade union relations (disclosure) | Worker consultation on top pay (disclosure) | 80%+ shareholder support on pay | CEO total pay (GBP) | CEO total pay change | CEO pay ratio (to median employee) | Gender pay (women % in top quartile) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AstraZeneca plc |  |
 |
— | |
|
|
|
15,323,000 | 10.57% | 159:1 | 41% |
| ConvaTec Group plc | |
|
— | |
|
|
|
4,341,000 | 15.7% | 98:1 | 42% |
| GSK plc | |
|
— | |
|
|
|
8,453,000 | 3.05% | 106:1 | 45.85% |
| Haleon plc | |
|
— | |
|
|
|
2,350,000 | — | 33:1 | 41.40% |
| Hikma Pharmaceuticals plc | |
|
— | |
|
|
|
4,617,436 | 17.25% | — | — |
| Smith & Nephew plc | |
|
— | |
|
|
|
5,419,451 | 135.42% | 107:1 | 41% |